Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 22, 2021, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg".
Press Release Jan 22 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Alembic Pharmaceuticals Limited on 6ix
Earlier from Alembic Pharmaceuticals
- Press Release Dec 11 2020
- Press Release Dec 03 2020
- Press Release Dec 02 2020
- Press Release Nov 25 2020
- Press Release Nov 09 2020
Later from Alembic Pharmaceuticals
- Press Release Feb 09 2021
- Press Release Feb 12 2021
- Press Release Mar 04 2021
- Press Release Apr 01 2021
- Press Release Apr 08 2021
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals